After the book that inspired a generation of neuroscientists and our research - multiscale brain investigations | PI: @DrValiante | @UHN | @UofT |@KBI_UHN
Tomorrow is #PurpleDay!
Dr. Taufik Valiante, neurosurgeon & scientist at @UHN’s Krembil Research Institute, shares insights on #epilepsy.
With donor support, we can find answers to the biggest questions & challenges in health care➜ https://t.co/ATcDrPJARa
@KBI_UHN @DrValiante
On #InternationalWomensDay, we celebrate the incredible women driving progress in epilepsy research—scientists, advocates, and those living with epilepsy. Your strength and dedication inspire us to keep pushing for breakthroughs!
Women make up 73% of #TeamUHN, and their dedication is transforming patient care, research and education every day. 💜
@UHN wouldn’t be Canada’s #1 hospital without their world-changing impact.👏
#InternationalWomensDay#IWD#UHNITED
Women comprise more than 73% of #TeamUHN.
Simply put, UHN could not be Canada’s no. 1 hospital without the dedication and excellence of women working across patient care, research, and education each day.
#InternationalWomensDay#IWD
Epilepsy doesn't discriminate – it can affect anyone, regardless of age, gender, or background.
Which is why we're dedicated to creating better treatments that empower individuals with epilepsy to live their lives to the fullest.
In celebration of #IWD, UHN Women hosted a discussion about menopause and the workplace. It is vital that we engage in dialogues that impact so many of our #TeamUHN friends and colleagues.
Thank you to all who joined us in-person or virtually, and to our speakers and panelists!
It’s Epilepsy Awareness Month!
Learn how Toronto is leading the way in neuromodulation innovation @CRANIA_Toronto@mpc_utoronto
@DrValiante speaks with #Neurotech@UofT about the latest neuromodulation advancements in epilepsy treatment.
🔗: https://t.co/cp3OlWuwok
Epilepsy doesn't discriminate – it can affect anyone, regardless of age, gender, or background.
Which is why we're dedicated to creating better treatments that empower individuals with epilepsy to live their lives to the fullest.
🧠💜 Today, on #WorldEpilepsyDay, we stand with the 50M+ people worldwide living with epilepsy. At N2BL, we're committed to advancing research, raising awareness, and breaking stigma. Together, we can make a difference! #EpilepsyAwareness#endthestigma@KBI_UHN@UHN
On Monday, February 10th, we observed World Epilepsy Day—a day to raise awareness, promote understanding, and support those affected by epilepsy. At the Neuron to Brain Lab, we’re proud and honored to continue spreading awareness every day! #WorldEpilepsyDay
Congratulations!
Our co-director @DrValiante and one of our scientists Dr. Ian Connell received $1.9 million in funding to develop advanced MRI technology for neuromodulation.
Three @UHN research projects have received over $4M through the Ontario Research Fund, part of a $92M investment in Ontario research!
Learn how this funding advances:
▶️#MRI tech
▶️#AI for donor lungs
▶️Muscle & joint health
Congrats to the awardees!
🔗 https://t.co/PyB70NSXq5
A bittersweet new preprint alert, the last of my work at @KBI_UHN@UHN_Research!
Jeremie Lefebvre, @DrValiante and I computationally deciphered how h- and m-channel over expression promote seizure.
For more… come find me on that OTHER site 😉
https://t.co/6lUAhHvH2C